Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £238.99m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Trading Update

19 May 2016 07:00

RNS Number : 6525Y
Science Group PLC
19 May 2016
 

 

19 May 2016

 

 

Science Group plc

(the "Company")

 

 

Trading update

 

Science Group plc provides the following update ahead of the Company's Annual General Meeting this morning.

 

Overall the Group performance in the first 4 months of the year is in line with the Board's expectations. At 30 April 2016, the Group had gross cash of £18.4 million and net funds of £10.9 million.

 

As a science-based services business with limited forward visibility, the Group has seen the benefits from the increase in diversification of client end-markets derived from the acquisition programme. In Q1, the Oil & Gas market continued to be challenging and the Medical business continued to suffer from the lack of new projects to replace those completed in 2015. However, following a change in Group management structure and US sales leadership, a number of significant projects have been won in the Medical sector in recent months which should improve performance in this business for the remainder of the year. The Group's other three business areas have performed satisfactorily, with Leatherhead (food & beverage) outperforming the Board's expectations in terms of profit contribution. As a result, in aggregate, Group revenue and adjusted operating profit to date are in line with the Board's expectations.

 

With a significant proportion of the Group's revenue denominated in US Dollars or Euros, there is an inherent sensitivity within the financial results related to foreign currency exchange fluctuations. While this effect impacts most international companies, IFRS accounting results in Science Group being particularly susceptible due to the majority of the Group's non-Sterling denominated invoices being raised directly from the UK. In brief, IFRS accounting requires that in this operating model, the balance sheet (debtor and WIP) of the relevant operating UK subsidiary is revalued each month with any positive or negative movement being recognised in the Group P&L; in the case where the non-Sterling revenues are invoiced from an in-country subsidiary, such variances would be recognised directly in reserves, although in pre-tax cash terms there is no material difference. This accounting anomaly results in significant additional FX volatility in the reported IFRS Group P&L statement but has the cash benefit of recording profits in the UK (where the work is undertaken) with its lower corporation tax rate. The recent volatility in Sterling-US Dollar exchange rates has brought this issue into sharp focus but the Board considers that the cash benefit to the Group outweighs the non-cash IFRS P&L reporting volatility.

 

The works at Great Burgh, Epsom have now received planning consent and, despite the delays in this process, relocation of the Leatherhead and OTM businesses remains on track to be completed over the summer. Approximately 80 employees are now based at Epsom and feedback from client events held there in recent weeks has been excellent. Following the purchase of the Great Burgh freehold property, the Board has now commenced negotiations regarding the possibility of increasing the Group's banking facilities, such debt to be secured on the Group's substantial freehold property assets which had a carrying value of £20.9 million as at 31 December 2015.

 

- Ends -

 

For further information:

Science Group plc

Martyn Ratcliffe, Chairman

Tel: +44 (0) 1223 875 200

Rebecca Hemsted, Finance Director

 

Numis Securities Limited

Nominated Adviser: Simon Willis / Paul Gillam

Tel: +44 (0) 20 7260 1000

Corporate Broking: Michael Burke

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUWVVRNRAVAAR
Date   Source Headline
16th Mar 20227:00 amRNSAudited Results for year ended 31 December 2021
14th Mar 202211:00 amRNSNotice of Preliminary Results
7th Feb 20227:00 amRNSDirector update
13th Jan 20227:00 amRNS2021 End of Year Trading Update
4th Jan 20223:56 pmRNSTotal Voting Rights
24th Dec 20217:00 amRNSNew Bank Facility
21st Dec 20215:10 pmRNSTransaction in Own Shares
20th Dec 20217:00 amRNSTransaction in Own Shares
16th Dec 202110:30 amRNSCredit Facility to TP Group
26th Nov 20217:00 amRNSFrontier, acquisition and group update
29th Oct 20215:00 pmRNSWithdrawal of GM Requisition - Replacement
29th Oct 20211:20 pmRNSWithdrawal of GM Requisition
26th Oct 20217:00 amRNSRequisition of General Meeting of TP Group plc
15th Oct 20217:00 amRNSIssue of share options & PDMR dealing
11th Oct 20217:00 amRNSTrading and Business Update
30th Sep 20214:45 pmRNSTotal Voting Rights
30th Sep 202111:45 amRNSResult of General Meeting
15th Sep 20217:00 amRNSTR1: Notification of Major Interest in Shares
13th Sep 20214:30 pmRNSTR1: Notification of Major Interest in Shares
13th Sep 20217:00 amRNSNotice of General Meeting
10th Sep 20217:00 amRNSHolding(s) in Company
9th Sep 20217:00 amRNSTP Group General Meeting
8th Sep 20212:00 pmRNSReplacement: Holding(s) in Company
8th Sep 202111:59 amRNSTR1: Notification of Major Interest in Shares
8th Sep 20217:00 amRNSTR1: Notification of Major Interest in Shares
8th Sep 20217:00 amRNSHolding(s) in Company
7th Sep 20211:48 pmRNSConfirmation of fundraising and director dealing
7th Sep 202111:16 amRNSProposed equity placing and director dealing
3rd Sep 202112:00 pmRNSWithdrawal of Possible Offer for TP Group plc
2nd Sep 20215:30 pmRNSHolding(s) in Company
2nd Sep 20217:00 amRNSForm 8 (DD) - TP Group plc
27th Aug 20215:27 pmRNSForm 8 (DD) - TP Group plc
27th Aug 20217:00 amRNSHolding(s) in Company
27th Aug 20217:00 amRNSForm 8 (DD) - TP Group plc
26th Aug 20217:00 amRNSForm 8 (DD) - TP Group plc
26th Aug 20217:00 amRNSForm 8 (DD) - TP Group plc
26th Aug 20217:00 amRNSForm 8 (DD) - TP Group plc
25th Aug 20212:20 pmRNSForm 8 (DD) - TP Group plc
25th Aug 20217:00 amRNSForm 8 (DD) - TP Group plc
24th Aug 20215:47 pmRNSHolding(s) in Company
24th Aug 20211:15 pmRNSHolding(s) in Company
24th Aug 20217:01 amRNSStatement re Final Possible Offer for TP Group plc
24th Aug 20217:00 amRNSForm 8 (DD) - TP Group plc
23rd Aug 20216:15 pmRNSHolding(s) in Company
23rd Aug 20215:12 pmRNSForm 8.3 - Science Group Plc
23rd Aug 20214:52 pmRNSForm 8.3 - Science Group Plc
23rd Aug 20214:50 pmRNSForm 8.3 - Science Group Plc
23rd Aug 20219:53 amRNSForm 8.5 (EPT/RI)
23rd Aug 20217:00 amRNSHolding(s) in Company
23rd Aug 20217:00 amRNSForm 8 (DD) - TP Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.